UPDATED ON FEB 03, 2021 08:18 AM IST
A new research has provided some reassurance that swift cases of reinfection will be rare as scientists find antibodies persisting for long in those infected with Covid-19 previously
UPDATED ON JAN 22, 2021 11:14 AM IST
- US drugmaker Eli Lilly recently did a study that showed her antibody drug might be capable of preventing Covid-19 illness in residents of nursing home and other long-term care locations.
Hindustan Times, Dehradun | By Suparna Roy
UPDATED ON SEP 24, 2020 10:11 PM IST
Convalescent plasma therapy involves extraction of plasma from the blood of Covid-19 patients four weeks after they have been cured of their viral infection. The extracted plasma is injected into Covid-19 patients. The antibody that develops in a recovered patient helps other Covid-19 patients to fight the virus.
New Delhi | By Press Trust of India| Posted by Zarafshan Shiraz
UPDATED ON SEP 07, 2020 08:19 PM IST
Given that there are neutralising antibodies and also ‘simple’ antibodies, Indian scientists reveal that it may not be that useful to stop further spread of the coronavirus
New Delhi | By Press Trust of India | Posted by Zarafshan Shiraz
UPDATED ON SEP 05, 2020 10:11 AM IST
Indian researchers understand coronavirus infection recovery and re-infection pattern better after study reveals that anti SARS-CoV-2 antibodies could remain for more than 60 days in the body
Hindustan Times, New Delhi | By HT Correspondent
UPDATED ON SEP 01, 2020 10:28 AM IST
Sero surveys help to know the chunk of population that may have contracted the virus and recovered from the disease without realising it.
By Bloomberg | Posted by Prashasti Singh
UPDATED ON AUG 26, 2020 06:54 PM IST
While the protective role of antibodies against infection isn’t fully understood, they are generally considered a good representation of some protection against infection in general, according to the report.
Hindustan Times, New Delhi | By Sanchita Sharma
UPDATED ON MAY 06, 2020 07:47 PM IST
Scientists in the Netherlands and Israel have separately created antibodies in the lab that can neutralise Sars-CoV-2, the virus that causes Covid-19, to prevent human cells from getting infected.